# Anxiolytic-like Activity, Antioxidant Properties, and Facilitatory Effects on the Short-Term Memory Retention of Molsidomine in Rats

**Authors:** Liliana Mititelu-Tartau, Maria Bogdan, Liliana Lăcrămioara Pavel, Ciprian Rezus, Cezar Ilie Foia, Nicoleta Dima, Irina Luciana Gurzu, Ana-Maria Pelin, Beatrice Rozalina Buca

PMC · DOI: 10.3390/life14030306 · 2024-02-26

## TL;DR

This study shows that molsidomine reduces anxiety, boosts antioxidants, and improves short-term memory in rats.

## Contribution

The study demonstrates molsidomine's anxiolytic, antioxidant, and memory-enhancing effects in a rat model.

## Key findings

- Molsidomine reduced spontaneous behavior and exploratory skills in rats.
- Molsidomine increased spontaneous alternation in the Y-maze test, indicating improved spatial memory.
- Molsidomine elevated brain-derived neurotrophic factor and antioxidant enzyme activity.

## Abstract

Compelling evidence indicates that nitric oxide (NO) exerts a significant influence on the central nervous system, participates in the modulation of neurotransmitter release, contributes to the regulation of cognitive functions, and plays a crucial role in modulating various aspects of neural activity. We aimed to explore the influence of two NO donors, molsidomine (MSD) and V-pyrro/NO, on the innate spontaneous psychomotor abilities and short-term memory in rats. Using an actimeter test, the locomotor activity, stress-sensitive behavior, and anxiety level were investigated. The influence on the animal`s cognitive functions was evaluated usingthe Y-maze test to assess the spontaneous alternation percentage, number of arms visited, number of alternations, and the preference index. Four distinct groups of five white male Wistar rats were exposed to the intraperitoneal treatments as follows: Control batch—0.3 mL/100 g of body weight saline solution, Mg batch—200 mg/kbwof magnesium chloride, MSD batch—1 mg/kbw of molsidomine, and V-pyrro/NO batch—5 mg/kbwof V-pyrro/NO. The intraperitoneal administration of MSD resulted in a significant reduction in spontaneous behavior and exploratory skills but was less pronounced than the positive control drug, magnesium chloride. Conversely, treatment with V-pyrro/NO led to only a slight decrease in horizontal movements during the actimeter test. MSD administration, but not V-pyrro/NO, notably increased the rate of spontaneous alternation in the Y-maze test. Additionally, the use of MSD resulted in an increase in the blood level of brain-derived neurotrophic factor and the intensification of the antioxidant enzymes, superoxide dismutase, and glutathione peroxidase activity. In our experimental setup, we demonstrated that MSD exposure led to a decrease in spontaneous behavior, showed anxiolytic effects and antioxidant activity, and improved spatial memory acquisition in rats.

## Linked entities

- **Proteins:** GPX2 (glutathione peroxidase 2)
- **Chemicals:** molsidomine (PubChem CID 5353788), V-pyrro/NO (PubChem CID 9605288), magnesium chloride (PubChem CID 5360315), nitric oxide (PubChem CID 145068)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225]
- **Diseases:** reduction in (MESH:D015431), anxiety (MESH:D001007)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10971537/full.md

---
Source: https://tomesphere.com/paper/PMC10971537